FDA Inspection 1283802 - Baxter Oncology GmbH - September 26, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Baxter Oncology GmbH

Record Details

This FDA Inspection record concerns Baxter Oncology GmbH, with an inspection on September 26, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Baxter Oncology GmbH
Inspection Date: September 26, 2025
Product Type: Human Drugs
Office: Office of Inspections and Investigations

Open in Dashboard

ID · d2cc3497-33d6-41da-be71-fed681081e29

Violation Codes10

21 CFR 211.100(a)21 CFR 211.113(b)21 CFR 211.160(b)21 CFR 211.186(a)21 CFR 211.19221 CFR 211.22(a)21 CFR 211.42(c)(10)(iv)21 CFR 211.42(c)(10)(v)21 CFR 211.56(a)21 CFR 211.63

Full citation text and observation details available on the Dashboard.